Company logo
December 2016
open in browser image

Transcranial Magnetic Stimulation (TMS)

Transcranial Magnetic Stimulation (TMS) may sound like something out of the future, a sci-fi venture fit for the likes of a Steven Spielberg creation. In reality, TMS was FDA approved in 2008 as a method for treating clinical depression that is rapidly gaining traction in the world of mental health. Providers and patients alike are beginning to see substantial, lasting results and health care companies across the country continue to sign on to cover the treatment.

Neurostar TMS therapy is the first Transcranial Magnetic Stimulation therapy approved by the FDA, and its success to date has been remarkable. In clinical trials, nearly 60% of patients showed significant improvement from their symptoms and 37% of those patients reported complete remission after the full treatment course. The word has begun to spread, and as a result patients from all walks of life are speaking out about their personal experiences with TMS.

product image
product image

Success Stories

In March of this year while speaking of his lifelong struggle with depression, comedian Neal Brennan, during an interview with Trevor Noah for The Daily Show stated, “I tried something called TMS that worked great, it’s Transcranial Magnetic Stimulation. […] I did it, and it actually did more for my depression than anything I’ve ever done.”

Brennan is not the first to publicly endorse this treatment. In her 2013 memoir – Martha’s story: 3,000 Pulses Later: A memoir of Surviving Depression Without Medication, poet and teacher Martha Rhodes described her depression as, “constant anxiety, sadness, fear, and despair,” that, “strangled me.” She wrote, “I felt inexorably alone and as if I were dying a slow death of emotional asphyxiation.” For Rhodes TMS was not, at that point, covered by her insurance, which left her with the choice of moving forward with Electroconvulsive Therapy (ECT), which was covered, yet highly worrisome to Rhodes due to the potential for memory loss, or investing in a new treatment she’d only read about in a magazine. Rhodes was particularly interested in the fact that unlike ECT, TMS does not require anesthesia and is an outpatient procedure. Rhodes discussed this research with her doctor and decided to move forward with the treatment.

The decision turned out to be a life changing one. “Somewhere around my 20th session [of TMS] I woke up one morning and that disgusting “UGH!!” feeling was gone,” Rhodes said, “a gentle lightness came over me as if I was lifted out of a dark hole.” This is precisely the type of result that Neurostar is hoping for, and the science behind how the treatment works so effectively supports Rhodes’s lasting success.

How it Works

TMS therapy works by using highly focused magnetic pulses, similar to an MRI, to stimulate specific areas of the brain that are shown to be underactive in patients with depression. Through targeted stimulation, the root cause of depression is addressed directly, without the negative side effects caused by oral antidepressants, which have to travel throughout the whole body before reaching the brain. Transcranial Magnetic Stimulation therapy is a daily, thirty-eight to fifty minute treatment that is administered five days per week for 6 weeks. Patients are able to resume their normal daily activities immediately following the treatments.

We are excited here at Siyan Clinical to be able to offer TMS to our patients. We have seen amazing results in the first patients who have graduated from our program. Please talk to your provider or call our office to speak to one of our TMS Technicians at (707) 206-7268 for more information.

Book of the Month

product image

We discussed Martha’s story author of this book

Stay in Touch!

facebook link
twitter link

This email was sent to [email] when you signed up on Siyan Clinical Corporation Please add us to your contacts to ensure the newsletters land in your inbox.

Siyan Clinical Corporation

480 Tesconi Circle, Suite B, Santa Rosa, CA 95401